Most cited papers from Siamab Therapeutics (United States)
What are the most cited papers from Siamab Therapeutics (United States)?
The most cited paper from Siamab Therapeutics (United States) is "Ovarian cancer stem cells: What progress have we made?" (Linah Al-Alem, Unnati M. Pandya, Andrew T. Baker et al., 2018), with 89 citations. Next come "Novel anti-Sialyl-Tn monoclonal antibodies and antibody-drug conjugates demonstrate tumor specificity and anti-tumor activity" (89) and "Humanized anti-Sialyl-Tn antibodies for the treatment of ovarian carcinoma" (54).
Showing 7 of 7 papers. Every paper is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Ovarian cancer stem cells: What progress have we made? Linah Al-Alem, Unnati M. Pandya, Andrew T. Baker et al. · The International Journal of Biochemistry & Cell Biology | 17 Dec 2018 | 89 |
| 2 | Novel anti-Sialyl-Tn monoclonal antibodies and antibody-drug conjugates demonstrate tumor specificity and anti-tumor activity Jillian M. Prendergast, Ana Paula Galvao da Silva, David A. Eavarone et al. · mAbs | 22 Feb 2017 | 89 |
| 3 | Humanized anti-Sialyl-Tn antibodies for the treatment of ovarian carcinoma David A. Eavarone, Linah Al-Alem, Alexey A. Lugovskoy et al. · PLoS ONE | 27 Jul 2018 | 54 |
| 4 | Treatment of ovarian cancer by targeting the tumor stem cell-associated carbohydrate antigen, Sialyl-Thomsen-nouveau Kristen D. Starbuck, Linah Al-Alem, David A. Eavarone et al. · Oncotarget | May 2018 | 42 |
| 5 | The novel anti-androgen candidate galeterone targets deubiquitinating enzymes, USP12 and USP46, to control prostate cancer growth and survival Urszula Lucja McClurg, Mahsa Azizyan, Daniel T. Dransfield et al. · Oncotarget | 18 May 2018 | 33 |
| 6 | Sialyl-Tn serves as a potential therapeutic target for ovarian cancer Linah Al-Alem, Jillian M. Prendergast, Justin Michael Clark et al. · Journal of Ovarian Research | 2 Apr 2024 | 15 |
| 7 | Production of a mouse monoclonal IgM antibody that targets the carbohydrate Thomsen-nouveau cancer antigen resulting in in vivo and in vitro tumor killing Kevin R. Trabbic, Kristopher A. Kleski, Meng‐Chao Shi et al. · Cancer Immunology Immunotherapy | 20 Jul 2018 | 15 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.